Jonathan Rich is a principal at Algerine Advisors LLC and a senior advisor at Apollo Global Management, Inc. They previously served as chairman and CEO at Berry Global, Inc. and held various prominent leadership roles at companies such as Lumileds and Momentive. Currently, Jonathan is a board member at Intrommune Therapeutics and Novolex, and also a visiting lecturer at Cornell University's Johnson/Dyson School of Business. They hold a Bachelor of Applied Science in Chemistry from Iowa State University and a PhD in Organic Chemistry from the University of Wisconsin-Madison.
This person is not in the org chart
This person is not in any teams
This person is not in any offices